Pulmonary Fibrosis

• CLINICAL_TRIALS withdrawal · 2024-12-10
  Clinical Trial Update: Safety of Nintedanib in Real World in China

  The real-world safety study of nintedanib in China (NCT05676112) sponsored by Boehringer Ingelheim has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2017-05-02
  Clinical Trial Update: Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung Cancer [NA]

  The clinical trial evaluating losartan for pulmonary fibrosis in patients with stage I–III non-small cell lung cancer has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2016-02-09
  Clinical Trial Update: Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis [Phase 2]

  A Phase 2 study of oral treprostinil for pulmonary hypertension associated with pulmonary fibrosis has been withdrawn.